Chapters

Transcript

Video

What is the current mainstay of treatment for CAH? What are the short- and long-term complications of present approaches—based on corticosteroid therapy—that encourage development of alternative therapies?

What is the current mainstay of treatment for CAH? What are the short- and long-term complications of present approaches—based on corticosteroid therapy—that encourage development of alternative therapies?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Patricia Fechner, MD

Patricia Fechner, MD

Medical Director, DSD Program
Medical Director, CAH Program
Co-Director, Turner Syndrome Clinic
Seattle Children’s Hospital
Professor of Pediatrics
University of Washington School of Medicine
Seattle, WA